Antiplatelet therapy for secondary prevention of lacunar stroke: a systematic review and network meta-analysis.

Huisheng ChenKaiwen CenYing CuiYuhong ZhangXu Feng

Published in: European journal of clinical pharmacology (2022)

This meta-analysis suggests that cilostazol may be a priority option for secondary prevention of patients with LS. These findings still need further study in the future.

Keyphrases

antiplatelet therapy
systematic review
acute coronary syndrome
percutaneous coronary intervention
atrial fibrillation
current status
randomized controlled trial
subarachnoid hemorrhage